Display options
Share it on

Cureus. 2018 Jun 23;10(6):e2869. doi: 10.7759/cureus.2869.

A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration.

Cureus

Dustin Harris, David Harter

Affiliations

  1. Emergency Department, The University of Chicago Medicine, Chicago, USA.

PMID: 30148021 PMCID: PMC6107327 DOI: 10.7759/cureus.2869

Abstract

Emergency physicians should be aware of adverse drug reactions prior to administering medication. Alteplase, or tissue plasminogen activator (tPA), is a common medication in the emergency department, whether it is being used for a stroke or pulmonary embolus. Angioedema can be caused by almost any medication. tPA administration can cause an atypical form of angioedema. The following case was one of unilateral orolingual angioedema associated with tPA administration in the emergency department in a stroke patient. The mechanism of tPA-induced angioedema is poorly understood. Angioedema can be treated with stopping the infusion of medication, Benadryl® (Johnson & Johnson Consumer, Inc., Fort Washington, PA), histamine antagonists, steroids, and epinephrine. Angioedema is a life-threatening event in certain situations, and emergency medicine providers would do well knowing how to approach these cases.

Keywords: alteplase; angioedema; orolingual; stroke; tpa; unilateral

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. N Am J Med Sci. 2013 Oct;5(10):589-93 - PubMed
  2. Stroke. 2016 Jul;47(7):1825-30 - PubMed
  3. World J Emerg Med. 2015;6(1):74-6 - PubMed
  4. Immunol Allergy Clin North Am. 2017 Aug;37(3):467-481 - PubMed
  5. West J Emerg Med. 2015 Jan;16(1):175-7 - PubMed
  6. Neurohospitalist. 2015 Jul;5(3):133-41 - PubMed
  7. Iran J Neurol. 2015 Oct 7;14(4):225-7 - PubMed

Publication Types